The U.S. has recorded 7,045 clinical Candida auris cases as of Dec. 20 — a 56.1% increase from the 4,514 cases logged in 2023, according to CDC data. About half of those cases are in Nevada and ...
China’s increasing economic footprint in Brazil, Latin America’s largest economy, is redefining the region’s balance of power. Once primarily a trading partner, China is now entrenching itself in the ...
A critical mount that kept the left engine attached to the UPS flight that crashed in Louisville earlier this month failed only moments after the doomed flight broke ground, according to a new report ...
After rumors leading up to the announcement, Valve finally unveiled Steam's new hardware lineup: a new controller, a hybrid PC-console called Steam Machine, and a new VR headset — Steam Frame.
Steam Frame, Valve’s next VR headset, has been announced, but the company has yet to reveal the price. However, the company says its goal is for Frame to be cheaper than its first VR headset. Steam ...
Round-the-clock fetal monitoring leads to unnecessary C-sections. But it’s used in nearly every birth because of business and legal concerns, The Times found. Round-the-clock fetal monitoring leads to ...
Here are the coolest developmental features that Adobe showcased at Max. Here are the coolest developmental features that Adobe showcased at Max. is a news writer focused on creative industries, ...
Forbes contributors publish independent expert analyses and insights. I write about how to do more with your consumer gadgets. Aura is shaking things up a bit and using the same tech that powers your ...
Comet C/2025 R2 (SWAN) will make a close flyby of Earth on Oct. 21. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Breaking space news, the ...
Hosted on MSN
If You'd Invested $1,000 in Recursion Pharmaceuticals 4 Years Ago, Here's How Much You'd Have Today
Recursion Pharmaceuticals has significantly lagged the market since its 2021 IPO. The company's potentially revolutionary approach has yet to produce results. The stock's upside is enormous if ...
This AI company isn't yet living up to the hype. Let's discuss Recursion Pharmaceuticals' performance over the past four years and whether the company can deliver solid returns in the future. It can ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.41187 EPS, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results